Tribunals and CommissionsDivision Bench(2004) 10 IPAB CK 0016

Ranbaxy Laboratories Ltd. vs Vets Farma (Private) Ltd. And Ors.

Intellectual Property Appellate Board · Decided on 1 October 2004 · Citation: (2005) 31 PTC 116 (IPAB)

HON’BLE JUDGES
S. Jagadeesan, J · Raghbir Singh, J
RESULT
Allowed
CASE NUMBER
T.A. No. 115/2003/TM/DEL (CM(M) No. 325/95)

CourtKutchehry membership

More clarity. Every judgment.

Download court copies, explore connected cases and make more of every research session.

Loading membership options…

Ask AI about this case

AI Structured Summary

Not yet generated for this judgment

Judgment

77 paragraphs · 1,719 words

S. Jagadeesan, J

1.

The appeal has been directed against the order of the Deputy Registrar of Trade Marks, New Delhi dated 14.6.95. Respondent herein M/s Vets

Farma (Private) Limited filed Application No. 495270 on 1.8.88 to register the trade mark 'LEVASOL' in respect of 'veterinary-medicines' included in

class 5 of the Trade and Merchandise Marks Act, 1958 (hereinafter referred to as the Act). The said application was advertised in the Trade Marks

Journal No. 1066 dated 1.11.93 at page 785.

2.

Ranbaxy Laboratories Limited, appellant herein filed their opposition No. DEL 8400 on 25.1.94 opposing the registration of the respondent's mark

on the ground that they are the registered proprietors of the trade mark 'LEMASOL' under Application No. 409129B in class 5 in respect of

pharmaceutical preparations for human use and the mark applied for is deceptively similar to that of the respondent and therefore the impugned mark

is not registrable under Sections 9, 11(a), 11(e), 12(1) and 18(1) of the Act. The respondent filed the counter-statement on the material averments

contained in the notice of opposition and contended that they are the proprietors of the mark applied for which is prior in adoption and user to that of

the opponents in respect of veterinary medicines and that the impugned mark is not deceptively similar to that of the appellant. Both the parties filed

their evidence and after the completion of the procedure formalities the Deputy Registrar of Trade. Marks heard the matter. Finally under the

impugned order the Deputy Registrar disallowed the opposition filed by the appellant and directed the application of the respondent to proceed for

registration. Aggrieved by the same, the appellant filed the appeal CM (M) No. 325 of 1995 on the file of High Court of Delhi, which stood transferred

to this Board pursuant to Section 100 of the Trade Marks Act, 1999.

3.

We heard Shri A.R. Lall, learned counsel for the appellant and Shri M.R. Bhalerao, learned counsel for the first respondent. The contention of the

learned counsel for the appellant is that the Deputy Registrar had disposed the matter in a two paragraph order which clearly reveals the non-

application of mind by the concerned authority. The Deputy Registrar, being a quasi-judicial authority and his order being appealable, ought to have

given reasons for his conclusions. Absence of any reason in the order is sufficient ground for setting aside the same. Even on merits it could be seen

that both the marks are identical and similar and as such the respondent's mark is deceptively similar to that of the appellant's mark. Hence, the use of

the respondent's mark would definitely create confusion. Further, the distributing window being the same, medicine for veterinary use or human use do

not make any difference as there is every possibility of mixing up of the medicines in the pharmaceutical store. Hence, the Board may either remand

the matter to the Deputy Registrar for fresh disposal or taking into consideration the lapse of time, can dispose of the appeal on merits.

4.

For contra, learned counsel for the respondent contended that the Deputy Registrar had specifically mentioned that the impugned mark will not

cause any confusion especially due to the reason that the respondent's medicine is for veterinary use. As the medicines manufactured by both the

parties are meant for different use, there is no possibility of confusion and overruled the objections raised by the appellant under Sections 9, 11(a),

11(e), 12(1) and 18(1) of the said Act. Further it was contended that the respondent being the earlier user, their right is to be safeguarded in terms of

Section 33 of the said Act. Hence, the appeal is liable to be dismissed.

5.

We perused the impugned order of the Deputy Registrar. As rightly pointed out by the learned counsel for the appellant, the Deputy Registrar had

disposed the matter with the following two paragraphs:-

I have gone through the file carefully and come to the conclusion that there force in contention of the Ld. Counsel for the applicants since the

medicine for animals cannot be used for human beings and vice-versa. Therefore, I do not find and probability of confusion and deception likely to be

used amongst the purchasing public in respect of the rival marks as well as the rival goods. The applicants are also prior adopters and users of the

impugned mark.

I have gone through the file carefully and come to the conclusion that the opponents have failed to establish the grounds of opposition under Sections

9, 11(a), 11(e), 12(1) and 18(1) of the Act. I, therefore, do not prefer to consider the opponents objection in details.

From the above order of the Deputy Registrar it is clear that he had come to the conclusion that the impugned mark will not create any confusion

because the use of the goods under the impugned mark is for veterinary purpose and the purpose being a totally different one from that of the

appellant, there is no possibility of confusion. Deputy Registrar on this ground did not discuss anything in detail in respect of opposition raised by the

appellant under Sections 9, 11(a), 11(e), 12(1) and 18(1) of the Act. Though the order is liable to be set aside on the short grounds that the Deputy

Registrar has failed to discuss anything in detail, the question is whether the matter is to be remanded back or we ourselves can dispose of the same

on merits, taking into consideration of the time lag, that is, application for registration was filed in 1988. We are of the view that we ourselves can

dispose of the matter on merits instead of remitting the matter and give an opportunity for the parties for one more round which ultimately would delay

the finality in the matter.

6.

First we will take up the issue whether the marks are identical. Appellant's mark is a registered one having brand 'LEMASOL' in class 5 for human

consumption. The respondent's mark is 'LEVASOL'. Except the third letter, rest of the letters in both the marks are the same. Hence, the question is

how far the change of third letter in the respondent's mark would differentiate their mark. When both the marks are looked side by side except the

third letter, there is absolutely no difference. Hence, for a sudden look both the marks are visually identical. Only after a careful scrutiny one can

make out the difference. Phonetically also there is not much difference. To make a difference one has to spell the word very carefully and in a

different manner. For the normal pronouncement there will be confusion as both the words are almost identical. Hence, it cannot be said that the

respondent's mark is visually and phonetically not similar to that of the appellant's mark. Though the learned counsel for the respondent emphatically

contended that the respondent's mark is not similar, he did not elaborate his argument by pointing out the dissimilarity between the two. Hence, we find

that the marks of both the appellant and the respondent are identical and same and hence there is every possibility that respondent's use of the mark

would create confusion.

7.

Now we will consider whether a different use could solve the problem of confusion. One has to take note of the fact that both the marks are under

class 5. Appellant's mark may be for human consumption and the respondent's mark may be for veterinary consumption. But however the distributing

channel for the consumer is one and the same. When the storing place and the distributing channel being one and the same, we cannot with all

impunity rule out the possibility of confusion. We also cannot forget the fact that at the distribution centre or the distribution window only qualified

hands are dealing in the goods. When there is possibility of mixing up of the medicines, we have to be doubly careful because human value of life is

more. We do not want to refer to more judgments except the judgment of the Supreme Court in Cadila Health Care Ltd. v. Cadila Pharmaceuticals

Ltd., 2001 PTC 541 (SC) at page 560-561 in para 33 the learned Judges observed as follows:-

What is likely to cause confusion would vary from case to case. However, the appellants are right in contending that where medicinal products are

involved, the test to be applied for adjudging the violation of trade mark law may not be on a par with cases involving non-medicinal products. A

stricter approach should be adopted while applying the test to judge the possibility of confusion of one medicinal product one another by the consumer.

While confusion in the case of non-medicinal products may only cause economic loss to the plaintiff, confusion between the two medicinal products

may have disastrous effects on health and in some cases life itself. Stringent measures should be adopted especially where medicines are the

medicines of last resort as any confusion in such medicines may be fatal or could have disastrous effects. The confusion as to the identity of the

product itself could have dire effects on the public health.

The above principles laid down by the Apex Court clearly indicate the care to be taken in considering the confusion between the two medicinal

products. On the above principles if we consider the question of confusion in this case, definitely the plea of different user may not have any

significance when the distributing channel is the same. Remote possibility of confusion also must be ruled out in the case of medicinal products;

otherwise the same may be fatal to the human life. For these reasons we are unable to agree with the findings of the Deputy Registrar for disallowing

the opposition of the appellant. One more material to show the non-application of mind available in the impugned order is in the first paragraph, the

Deputy Registrar has mentioned that M/s. Vets Farma (Pvt.) Ltd. filed the notice of opposition to oppose the registration, whereas the notice of

opposition was filed by the appellant M/s Ranbaxy Laboratories Ltd. Consequently the appeal is allowed and the impugned order of the Deputy

Registrar of Trade Marks is set aside. The opposition of the appellant DEL 8400 is allowed and the application No. 495270 in class 5 of the

respondent shall stand rejected.